Here Are October’s Perfect Stocks

Perfect Company stocks oct

Momentum is once again positive as we kick off the second week of earnings season. With that said, I wanted to take a moment to talk about the companies with very attractive balance sheets. Remember, I’m not one for speculation around earnings season. I prefer to actively “trade” stocks that I already know are succeeding in this economy. If you’ve followed me on this before, you know I’m looking at three metrics to find these perfect companies. Some publications charge money for this type of analysis. 

But this is the ultimate Do-It-Yourself lesson. So, use these three metrics:

  • The Piotroski F-Score
  • The Altman Z-Score
  • A Valuation Rank

Let’s Talk About the Numbers

We want a story of positive growth – and the F Score tells it. The F-score is a NINE-POINT system that rewards each company for meeting a certain criterion on its balance sheet.  If the company meets all nine criteria, it has an F score of 9. 

The Z score is a weighted average of five metrics to determine whether a company might go out of business. For example, if a company falls below 2.5, it has a risky balance sheet – typically due to large debt loads or weak cash flow. 

I hate surprises, so I prefer to target companies with a Z score of 3 or higher. Remember, stocks with solid F and Z scores tell us RIGHT NOW what is working in the U.S. economy. You can’t fake performance when using forensic analysis. 

Here are the perfect companies this month. 

StockF ScoreZ Score
Hologic (NASDAQ:HOLX)94.06
SEI Investments (NASDAQ:SEIC)918.43
Quest Diagnostics (NYSE:DGX)94.34
Credit Acceptance Corp. (NASDAQ:CACC)93.34
Smith & Wesson Brands (NASDAQ:SWBI)99.41
SIGA Technologies (NASDAQ:SIGA)920.94
Natural Alternatives (NASDAQ:NAII)94.48

These are the types of stocks that I like to sell covered calls on. I want to trade Poor Man’s Covered Calls. And I like to dollar cost average them should they drop in price. You might also want to consider a cash-secured put as well to pick your entry price and generate some income in the process.

You can’t fake performance. That’s why I love this strategy.

Garrett Baldwin
Garrett Baldwin
Garrett Baldwin joined Godesburg Financial Publishing as Chief U.S. Markets Analyst in early 2021. A Johns Hopkins-trained Economist, he’s worked with hedge funds, venture capital firms, angel investors, and economic advisors to the U.S. government. Baldwin specializes in market anomalies and alternative investments. He’s written extensively on momentum, value, insider buying, and other unique strategies that provide investors that elusive edge.
Garrett Baldwin
Garrett Baldwin
Garrett Baldwin joined Godesburg Financial Publishing as Chief U.S. Markets Analyst in early 2021. A Johns Hopkins-trained Economist, he’s worked with hedge funds, venture capital firms, angel investors, and economic advisors to the U.S. government. Baldwin specializes in market anomalies and alternative investments. He’s written extensively on momentum, value, insider buying, and other unique strategies that provide investors that elusive edge.

Related Articles

biontech share

BioNTech Share Favorably Valued

Today we are talking about the Mainz-based biotech company BioNTech (BNTX). Similar to HelloFresh, this “fallen angel” is well worth a look. COVID-19 Vaccine Brings

Read More »